抗癌新药-话题@MedSci

#抗癌新药#

40篇内容 | 893人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1651222, encodeId=9dcd16512223c, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=又有抗癌新药来了！礼来Verzenio、安进Blincyto被纳入优先审评, objectType=article, longId=184663, objectId=917318466353, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=917318466353, replyNumber=0, likeNumber=29, createdTime=2020-04-13, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=917318466353, moduleTitle=又有抗癌新药来了！礼来Verzenio、安进Blincyto被纳入优先审评, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=917318466353)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651218, encodeId=0430165121863, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=国家卫健委：12种抗癌新药纳入新版基本药物目录, objectType=article, longId=160587, objectId=24b516058ed1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24b516058ed1, replyNumber=0, likeNumber=0, createdTime=2019-12-07, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24b516058ed1, moduleTitle=国家卫健委：12种抗癌新药纳入新版基本药物目录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24b516058ed1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651221, encodeId=af00165122121, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=抗癌新药获FDA突破性疗法认定，临床试验正在招募, objectType=article, longId=180911, objectId=b5e0180911c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5e0180911c6, replyNumber=0, likeNumber=41, createdTime=2019-11-12, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5e0180911c6, moduleTitle=抗癌新药获FDA突破性疗法认定，临床试验正在招募, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5e0180911c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651212, encodeId=ba1d165121252, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=别把抗癌新药当“神药”, objectType=article, longId=154807, objectId=995415480ed1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=995415480ed1, replyNumber=0, likeNumber=45, createdTime=2019-05-25, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=995415480ed1, moduleTitle=别把抗癌新药当“神药”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=995415480ed1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651214, encodeId=df3b1651214bf, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=我国自主研发抗癌新药达伯舒获准上市，价格将低于同类进口药, objectType=article, longId=157612, objectId=611715e61263, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=611715e61263, replyNumber=0, likeNumber=40, createdTime=2019-06-15, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=611715e61263, moduleTitle=我国自主研发抗癌新药达伯舒获准上市，价格将低于同类进口药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=611715e61263)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651220, encodeId=7c45165122026, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=吴令英：关注卵巢癌防治加速临床急需抗癌新药纳入医保, objectType=article, longId=162193, objectId=50b61621933c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50b61621933c, replyNumber=0, likeNumber=31, createdTime=2019-03-30, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50b61621933c, moduleTitle=吴令英：关注卵巢癌防治加速临床急需抗癌新药纳入医保, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50b61621933c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651208, encodeId=0ecb165120845, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=抗癌新药先行使用！上海建设药品进口枢纽口岸, objectType=article, longId=144026, objectId=20d3144026d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20d3144026d7, replyNumber=0, likeNumber=41, createdTime=2019-02-09, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20d3144026d7, moduleTitle=抗癌新药先行使用！上海建设药品进口枢纽口岸, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20d3144026d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651213, encodeId=55be16512131b, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=受管制审批延误欧洲抗癌新药上市要等多年, objectType=article, longId=155200, objectId=9a2d15520066, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a2d15520066, replyNumber=0, likeNumber=51, createdTime=2018-12-23, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a2d15520066, moduleTitle=受管制审批延误欧洲抗癌新药上市要等多年, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a2d15520066)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651219, encodeId=2f8a1651219fd, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=国产抗癌新药获批上市价格低于同类进口药, objectType=article, longId=161001, objectId=528416100158, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=528416100158, replyNumber=0, likeNumber=34, createdTime=2019-11-19, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=528416100158, moduleTitle=国产抗癌新药获批上市价格低于同类进口药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=528416100158)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651216, encodeId=6b55165121650, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=中国第一个获得美国FDA“突破性疗法”认证的抗癌新药到底好在哪？, objectType=article, longId=158826, objectId=ae6c15882697, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae6c15882697, replyNumber=0, likeNumber=31, createdTime=2019-07-08, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae6c15882697, moduleTitle=中国第一个获得美国FDA“突破性疗法”认证的抗癌新药到底好在哪？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae6c15882697)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651215, encodeId=1716165121539, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=我国抗癌新药研究登上国际期刊封面引关注, objectType=article, longId=157778, objectId=b6bf15e7783e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6bf15e7783e, replyNumber=0, likeNumber=0, createdTime=2019-02-07, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6bf15e7783e, moduleTitle=我国抗癌新药研究登上国际期刊封面引关注, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6bf15e7783e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651206, encodeId=4a2a1651206b5, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=J Natl Cancer Inst：FDA批准的抗癌新药一半以上然并卵, objectType=article, longId=140227, objectId=37dc14022e77, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37dc14022e77, replyNumber=0, likeNumber=26, createdTime=2018-08-05, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37dc14022e77, moduleTitle=J Natl Cancer Inst：FDA批准的抗癌新药一半以上然并卵, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37dc14022e77)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651217, encodeId=2d0d165121ecf, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=境外抗癌新药审批提速促境内同步上市, objectType=article, longId=159946, objectId=b3e515994690, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3e515994690, replyNumber=0, likeNumber=40, createdTime=2019-04-29, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3e515994690, moduleTitle=境外抗癌新药审批提速促境内同步上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3e515994690)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651209, encodeId=8d9f165120965, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=中国自主研发抗癌新药获批上市, objectType=article, longId=148407, objectId=cfd214840e23, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfd214840e23, replyNumber=0, likeNumber=36, createdTime=2018-10-03, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfd214840e23, moduleTitle=中国自主研发抗癌新药获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfd214840e23)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651210, encodeId=64e91651210f3, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=校企联合研发抗癌新药新疗法，中医药将为世界带来更多礼物, objectType=article, longId=150781, objectId=b7ff150e8199, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7ff150e8199, replyNumber=0, likeNumber=34, createdTime=2019-08-29, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7ff150e8199, moduleTitle=校企联合研发抗癌新药新疗法，中医药将为世界带来更多礼物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7ff150e8199)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651202, encodeId=667716512027f, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=Cell Chem Biol：新研究将帮助我们获得一类更好的抗癌新药！, objectType=article, longId=127520, objectId=b9df12e520ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9df12e520ca, replyNumber=0, likeNumber=39, createdTime=2018-12-09, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9df12e520ca, moduleTitle=Cell Chem Biol：新研究将帮助我们获得一类更好的抗癌新药！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9df12e520ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651211, encodeId=3ca21651211a8, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=抗癌新药入选医保目录，医保总额控制松动，价值支付浮出水面, objectType=article, longId=150793, objectId=2798150e9381, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2798150e9381, replyNumber=0, likeNumber=29, createdTime=2019-07-29, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2798150e9381, moduleTitle=抗癌新药入选医保目录，医保总额控制松动，价值支付浮出水面, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2798150e9381)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651204, encodeId=f94c165120411, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=Nat Commun：我国学者研发抗癌新药，可100%杀死肺癌等再生细胞, objectType=article, longId=136095, objectId=01f21360951d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01f21360951d, replyNumber=0, likeNumber=49, createdTime=2018-11-16, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01f21360951d, moduleTitle=Nat Commun：我国学者研发抗癌新药，可100%杀死肺癌等再生细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01f21360951d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651205, encodeId=988e1651205b2, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=上海主动出击！先行使用抗癌新药试点方案来了, objectType=article, longId=139144, objectId=d1fb139144aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1fb139144aa, replyNumber=0, likeNumber=45, createdTime=2018-10-30, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1fb139144aa, moduleTitle=上海主动出击！先行使用抗癌新药试点方案来了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1fb139144aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651207, encodeId=734b165120ead, content=<a href='/topic/show?id=1e61555223e' target=_blank style='color:#2F92EE;'>#抗癌新药#</a>, objectTitle=只有高质量的研究设计才是研发抗癌新药造福于全球癌症患者的基石, objectType=article, longId=140978, objectId=5c621409e82a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c621409e82a, replyNumber=0, likeNumber=45, createdTime=2018-08-14, rootId=0, userName=zhangmingxiang, userId=0a6224143528, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c621409e82a, moduleTitle=只有高质量的研究设计才是研发抗癌新药造福于全球癌症患者的基石, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c621409e82a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗癌新药

2020-05-29

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

又有抗癌新药来了！礼来Verzenio、安进Blincyto被纳入优先审评

2020-04-13

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

国家卫健委：12种抗癌新药纳入新版基本药物目录

2019-12-07

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

抗癌新药获FDA突破性疗法认定，临床试验正在招募

2019-11-12

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

别把抗癌新药当“神药”

2019-05-25

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

我国自主研发抗癌新药达伯舒获准上市，价格将低于同类进口药

2019-06-15

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

吴令英：关注卵巢癌防治加速临床急需抗癌新药纳入医保

2019-03-30

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

抗癌新药先行使用！上海建设药品进口枢纽口岸

2019-02-09

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

受管制审批延误欧洲抗癌新药上市要等多年

2018-12-23

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

国产抗癌新药获批上市价格低于同类进口药

2019-11-19

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

中国第一个获得美国FDA“突破性疗法”认证的抗癌新药到底好在哪？

2019-07-08

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

我国抗癌新药研究登上国际期刊封面引关注

2019-02-07

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

J Natl Cancer Inst：FDA批准的抗癌新药一半以上然并卵

2018-08-05

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

境外抗癌新药审批提速促境内同步上市

2019-04-29

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

中国自主研发抗癌新药获批上市

2018-10-03

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

校企联合研发抗癌新药新疗法，中医药将为世界带来更多礼物

2019-08-29

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

Cell Chem Biol：新研究将帮助我们获得一类更好的抗癌新药！

2018-12-09

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

抗癌新药入选医保目录，医保总额控制松动，价值支付浮出水面

2019-07-29

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

Nat Commun：我国学者研发抗癌新药，可100%杀死肺癌等再生细胞

2018-11-16

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

上海主动出击！先行使用抗癌新药试点方案来了

2018-10-30

zhangmingxiang (审核中...)

前往app查看评论内容

#抗癌新药#

只有高质量的研究设计才是研发抗癌新药造福于全球癌症患者的基石

2018-08-14

科室
- - 订阅+
  - 更多科室
工具
服务